Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
J Gastroenterol Hepatol ; 23(12): 1934-40, 2008 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-18717760

RESUMO

BACKGROUND AND AIM: Melibiose/rhamnose permeability test is used for noninvasive intestinal mucosa barrier testing. However, the possible escape route of the absorbed saccharides through either intact or impaired blood-biliary barriers has not so far been explored. The objective of the present study was therefore two-fold: First, to describe in detail the biliary pharmacokinetics of melibiose and rhamnose in rats; second, to evaluate the changes of both sugars' pharmacokinetics upon impairment of the blood-biliary barrier by acute extrahepatic cholestasis in rats. METHODS: Bile duct obstructed (BDO), sham-operated and intact (unoperated) male Wistar rats were administered, 24 h after the appropriate intervention, with a single intravenous dose of melibiose and rhamnose, and a 4-h pharmacokinetic study was performed. RESULTS: In intact animals, the biliary excretion of melibiose and rhamnose was only 0.06% and 0.4% of the administered dose, respectively, while the urinary excretion accounted for 70.6% and 61.7%, respectively. In BDO animals, the biliary excretion rate of both saccharides, especially that of melibiose, was increased with a consequent 4.4-fold rise of the biliary melibiose/rhamnose ratio, the accepted paracellular permeability indicator. Both, the renal clearance of melibiose and the urinary melibiose/rhamnose ratio remained uninfluenced by cholestasis. CONCLUSION: The present study is the first to describe in detail pharmacokinetic parameters and the biliary excretion of melibiose and rhamnose in healthy and cholestatic rats. The altered melibiose/rhamnose biliary excretion ratio in BDO rats indicates that the test is able to detect the impairment of the blood-biliary barrier in acute extrahepatic cholestasis.


Assuntos
Canalículos Biliares/metabolismo , Bile/metabolismo , Colestase/metabolismo , Melibiose/farmacocinética , Ramnose/farmacocinética , Junções Íntimas/metabolismo , Doença Aguda , Animais , Colestase/diagnóstico , Cromatografia Líquida de Alta Pressão , Técnicas de Diagnóstico do Sistema Digestório , Modelos Animais de Doenças , Injeções Intravenosas , Masculino , Melibiose/administração & dosagem , Melibiose/urina , Permeabilidade , Ratos , Ratos Wistar , Ramnose/administração & dosagem , Ramnose/urina , Regulação para Cima
2.
Biosci Biotechnol Biochem ; 71(11): 2774-80, 2007 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-17986780

RESUMO

We examined how dietary melibiose affected the T-helper (Th) cell responses induced by an orally fed antigen in ovalbumin (OVA)-specific T cell receptor transgenic mice (OVA 23-3). Dietary melibiose markedly decreased the Th2 type responses as shown by a significant decrease in the interleukin (IL)-4 production and T cell proliferative response induced by sensitization from the 7-d oral administration of OVA. It was additionally observed that the Th1 type responses tended to decrease. We therefore examined the effect of melibiose feeding on the induction of immunological tolerance induced by the oral administration of an antigen (oral tolerance). The Th cell responses induced in BALB/c mice by subcutaneous immunization with OVA were suppressed by the prior oral administration of OVA. Such responses in the OVA-fed and immunized mice were further diminished by dietary melibiose. These results suggest that dietary melibiose strongly affected the Th cell responses to an ingested antigen, and further demonstrate the potential of melibiose to enhance the induction of oral tolerance.


Assuntos
Carboidratos da Dieta/administração & dosagem , Tolerância Imunológica , Melibiose/administração & dosagem , Boca/imunologia , Células Th2/efeitos dos fármacos , Animais , Ativação Linfocitária , Camundongos , Camundongos Transgênicos , Ovalbumina/imunologia , Receptores de Antígenos de Linfócitos T alfa-beta/genética , Células Th2/imunologia
3.
Transplantation ; 58(3): 330-7, 1994 Aug 15.
Artigo em Inglês | MEDLINE | ID: mdl-8053057

RESUMO

Methods of inhibiting the hyperacute antibody-mediated rejection that occurs when pig organs are transplanted into primates have been investigated using the baboon as a potential recipient. Baboons were treated with different regimens that included combinations of (1) splenectomy, (2) pharmacologic immunosuppression (CsA, cyclophosphamide, corticosteroids +/- methotrexate), and (3) intravenous infusion of oligosaccharides. The cytotoxicity of the serum was then assessed on cultures of pig kidney cells (PK15). Unmodified serum caused approximate 65-100% pig cell destruction. Splenectomy and/or pharmacologic immunosuppression, and infusions of dextran, dextrose or mannitol, did not result in any reduction of cytotoxicity. Infusions of melibiose and/or arabinogalactan, both of which have terminal non-reducing alpha-galactose, however, decreased relative PK15 cell damage significantly in a dose-dependent manner. At high concentrations (< or = 50 g/hr), complete inhibition of cytotoxicity was achieved in 4 of 15 baboons. The extracorporeal immunoadsorption of baboon serum utilizing immunoaffinity columns of melibiose also resulted in a significant reduction (of approximately 80%) in cytotoxic effect. In 1 baboon, melibiose and arabinogalactan infusion delayed vascular rejection of a pig cardiac xenograft from 10 min to about 12 hr, at which time the baboon died from the toxic effects of the carbohydrate infusion. These observations (1) add further support to the role that anti-alpha-galactosyl antibodies play in the hyperacute rejection of pig tissues transplanted into primates, and (2) demonstrate that serum cytotoxicity can be reduced by the intravenous infusion of alpha-galactosyl oligosaccharides or by extracorporeal immunoadsorption using these carbohydrates.


Assuntos
Galactanos/administração & dosagem , Transplante de Coração/imunologia , Rim/citologia , Melibiose/administração & dosagem , Papio/sangue , Transplante Heterólogo , Animais , Citotoxicidade Celular Dependente de Anticorpos , Cromatografia de Afinidade , Galactose/imunologia , Técnicas de Imunoadsorção , Imunossupressores/farmacologia , Infusões Intravenosas , Suínos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA